openPR Logo
Press release

Diabetic Neuropathy Market Share 2023: Trends, Key Players, Industry Analysis and Forecast 2023-2029

03-11-2023 07:40 PM CET | Health & Medicine

Press release from: Orion Market Research

Diabetic Neuropathy Market Share 2023: Trends, Key Players,

The global diabetic neuropathy market is predicted to grow at a CAGR of over 6% during the forecast period. The factors driving the global diabetic neuropathy market include the rising prevalence of diabetes along with the neurological disorders among the peoples. Diabetic neuropathy is a common disorder for both types of diabetes patients that is type 1 as well as type 2. The main four disorders includes, autonomic neuropathy, affects the heart rate, digestion blood pressure along with other body functions.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/diabetic-neuropathy-market

The second one is peripheral neuropathy, which affects the nerves of the feet and legs, and causes loss of sensations in legs and hands. The third is proximal neuropathy, which directly affects thighs, legs, buttocks, and hips. Whereas, focal neuropathy affects the wrist, foot, thigh along with pain in the chest, back, and other body parts.

Rising geriatric population is also one of the key factors encouraging the growth of the global diabetic neuropathy market, as the older peoples are more prone to such diseases. According to WHO, the geriatric population is going to be double in 2050 as compared to 2000. In 2000, the global level proportion of the population over 65 years was 11% which is expected to be 22% by 2050. The geriatric population is expected to reach 2 billion by 2050 as compared to 605 million in 2010. Similarly, the number of geriatric populations over 80 years or older will be almost quadrupled to 395 million from 2000 to 2050.The rise in the geriatric population may also encourage the market during the forecast period.

Growing healthcare expenditures is another motivating factor for the growth of the global diabetic neuropathy industry. For instance, in the economies of Asia-Pacific, the healthcare systems are facing challenges such as the burden of increasing and aging population, delivery of adequate healthcare facilities to the masses, and low per capita income. The healthcare expenditure in these countries is growing significantly with the increasing interest from both the private and public sectors. Economies of the Asia-Pacific region (China and India) are amongst the fastest developing countries in the adoption and implementation of new technologies across the globe.

Further, the key players' contribution to the global diabetic neuropathy market growth is anticipated to be one of the major driving factors of the market. Abbott Laboratories, GlaxoSmithKline Plc, Lupin Ltd., Bioness Inc., and others are some of the key players operating the global diabetic neuropathy market. These key players are indulged in the rapid R&D activities regarding the development of novel and innovative treatment types of diabetic neuropathy during the forecast time frame.

Current Market Trends Covered in the Market Report:

• Increased investments by the government along with the private organizations concerning the early diagnosis and treatment of this severe disease is likely to positively affect the diabetic neuropathy market growth during the forecast period
• Peripheral neuropathy segment will account for significant growth in the diabetic neuropathy industry
• Novel product launches, rapid innovations along with the geographical expansion will be the key growth strategy adopted by the key players to sustain in the market.

Global Diabetic Neuropathy Market - Segmentation

By Treatment Type

• Medications
• Radiotherapy
• Physiotherapy
• Others

By Disorder Type

• Autonomic Neuropathy
• Peripheral Neuropathy
• Proximal Neuropathy
• Focal Neuropathy

A full report of Diabetic Neuropathy Market is available at: https://www.omrglobal.com/industry-reports/diabetic-neuropathy-market

Global Diabetic Neuropathy Market - Segmentation by Region

North America

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa
• Latin America

Company Profiles

• Abbott Laboratories, Inc.
• Achelios Therapeutics Inc.
• Bioness, Inc.
• CuronzLtd.
• Depomed Inc.
• Eli Lilly and Co.
• GlaxoSmithKline Plc
• Glenmark Pharmaceuticals Ltd.
• Innovus Pharmaceuticals, Inc.
• Johnson & Johnson
• Lupin Ltd.
• NeuroMetrix, Inc.
• Nevro Corp.
• NovaDX

Visit More Report at

https://www.asiatimeskorea.com/press-release/%eb%8b%a4%eb%85%84%ec%83%9d-%ec%95%8c%eb%a0%88%eb%a5%b4%ea%b8%b0-%eb%b9%84%ec%97%bc-%ec%95%bd%eb%ac%bc-%ec%8b%9c%ec%9e%a5-%eb%8f%99%ed%96%a5-%ec%97%b0%ea%b5%ac-%eb%b3%b4%ea%b3%a0%ec%84%9c-%ec%84%b1/214465/

https://www.diario-ya.com/regionales/%e8%9b%8b%e7%99%bd%e8%b4%a8%e8%b0%b7%e6%b0%a8%e9%85%b0%e8%83%ba%e4%bc%bd%e7%8e%9b%e8%b0%b7%e6%b0%a8%e9%85%b0%e8%bd%ac%e7%a7%bb%e9%85%b6-2-%e5%b8%82%e5%9c%ba%e8%b6%8b%e5%8a%bf%e3%80%81%e7%a0%94/288342/

https://sportmsr.com/%d8%a7%d9%84%d8%ad%d8%b5%d8%a9-%d8%a7%d9%84%d8%b3%d9%88%d9%82%d9%8a%d8%a9-%d9%84%d8%a3%d9%82%d8%b1%d8%a7%d8%b5-%d8%a7%d9%84%d8%b2%d8%b9%d9%81%d8%b1%d8%a7%d9%86-%d9%81%d9%8a-%d8%b9%d8%a7%d9%85-2022/

https://revistaeconomiasocial.com/2022/12/30/informe-de-mercado-de-medicamentos-para-la-esclerosis-multiple-progresiva-secundaria-2022-por-jugadores-clave-tendencias-tamano-participacion-y-pronostico-2022-2028/

https://monblogapple.com/2022/12/30/rapport-sur-le-marche-de-la-proteine-de-surface-gp-120-2022-par-acteurs-cles-tendances-taille-part-et-previsions-2022-2028/

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Diabetic Neuropathy Market Share 2023: Trends, Key Players, Industry Analysis and Forecast 2023-2029 here

News-ID: 2971191 • Views:

More Releases from Orion Market Research

Skin Biopsy Market Share, Trends, Growth, Analysis and Forecast 2023-2030
Skin Biopsy Market Share, Trends, Growth, Analysis and Forecast 2023-2030
The global skin biopsy market is anticipated to grow at a considerable CAGR of 6.8% during the forecast period (2023-2030). The rising demand of skin biopsy in skin cancer treatment is a key factor driving the growth of the global market. Skin biopsy help in differentiate between benign and malignant lesions, differentiate between cancer and non-melanoma cancers, and aid in immunohistochemistry (IHC) biomarker analysis. They also aid in research and
Pupillometer Market Increasing Demand, Growth Analysis and Future Outlook by 2030
Pupillometer Market Increasing Demand, Growth Analysis and Future Outlook by 203 …
The global pupillometer market is anticipated to grow at a CAGR of 6.85% during the forecast period (2023-2030). Pupillometers have a wide range of applications in the medical field. They are used in neurological assessments to monitor changes in pupil size and reactivity, providing valuable insights into a patient's neurological status. Additionally, pupillometers assist in critical care settings, ophthalmology, anesthesiology, and drug development and research, playing a crucial role in
Patient Registry Software Market Is Expected To Exhibit Significant Growth Over 2030
Patient Registry Software Market Is Expected To Exhibit Significant Growth Over …
The global patient registry software market is anticipated to grow at a CAGR of 8.6% during the forecast period (2023-2030). Patient registry software is used to create and manage registries that collect and store patient data related to a specific medical condition. It is additionally used for clinical research, public health initiatives, quality improvement, and chronic disease management. Patient registries are instrumental in advancing research, treatment, and care for patients
Toothpaste Market Increasing Demand, Growth Analysis and Future Outlook by 2031/ Colgate-Palmolive Co., GlaxoSmithKline plc, Johnson & Johnson
Toothpaste Market Increasing Demand, Growth Analysis and Future Outlook by 2031/ …
The global toothpaste market is anticipated to grow with a considerable CAGR during the forecast period. The daily usage of toothpaste aids in maintain cleanliness and freshens the mouth. Numerous advantages of toothpaste such as the rebuilding of enamel strength, protection against acids, protection against cavities, keeps teeth and gums healthy are the major factors driving the adoption of toothpaste. Additionally, the emphasis on maintaining personal appearance is increasing significantly

All 5 Releases


More Releases for Neuropathy

Diabetic Neuropathy Market Opportunity Analysis, 2018-2026
Diabetic Neuropathy is the damage caused to the nerve due to diabetes which often leads to pain and numbness in feet or lower legs. The pain can be experienced in other parts of the body such as hips, wrist and back depending upon the effect of neuropathy. There are different types of neuropathy such as focal neuropathy, proximal neuropathy, peripheral neuropathy and autonomic neuropathy. An estimated 50% of diabetic population
Diabetic Neuropathy Treatment Market Report 2018: Segmentation by Disorder Type …
Global Diabetic Neuropathy Treatment market research report provides company profile for Pfizer, Inc., Johnson & Johnson, Boehringer Ingelheim GmbH, NeuroMetrix, Inc., Astellas Pharma Inc., Eli Lilly and Company, GlaxoSmithKline plc, Lupin Limited, Depomed, Inc., Glenmark Pharmaceuticals Ltd and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue,
Diabetic Peripheral Neuropathy - Pipeline Review, H1 2018
"The Report Diabetic Peripheral Neuropathy - Pipeline Review, H1 2018 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Diabetic Peripheral Neuropathy Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Peripheral Neuropathy - Pipeline Review, H1 2018, provides an overview of the Diabetic Peripheral Neuropathy (Metabolic Disorders) pipeline landscape. "Diabetic neuropathy is nerve damage caused by diabetes. The type
Diabetic Neuropathy Market - Global Industry Analysis 2024
Diabetic Neuropathy is the damage caused to the nerve due to diabetes which often leads to pain and numbness in feet or lower legs. The pain can be experienced in other parts of the body such as hips, wrist and back depending upon the effect of neuropathy. There are different types of neuropathy such as focal neuropathy, proximal neuropathy, peripheral neuropathy and autonomic neuropathy. An estimated 50% of diabetic population
Diabetic Neuropathy Market - Global Industry Analysis 2025
Market Overview Diabetic Neuropathy is the damage caused to the nerve due to diabetes which often leads to pain and numbness in feet or lower legs. The pain can be experienced in other parts of the body such as hips, wrist and back depending upon the effect of neuropathy. There are different types of neuropathy such as focal neuropathy, proximal neuropathy, peripheral neuropathy and autonomic neuropathy. An estimated 50% of diabetic
Optic Neuropathy - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Optic Neuropathy - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Optic Neuropathy - Pipeline Review, H2 2017, provides an overview of the Optic Neuropathy (Ophthalmology) pipeline landscape. Optic neuropathy is an inherited form of vision loss. Symptoms include eye pain or discomfort, numbness, tingling and clouding